Full Description
This book addresses various aspects of recent progress in the development of all types of tumorresponsive and site-specific delivery platforms together with the range of related chemistries. It is a timely volume as global research in oncology is moving towards more biochemical signal-based and cell environment-inspired therapeutic strategies. Furthermore, the book emphasizes the need to explore various characterization techniques for specific stimuli-responsive nanoplatforms and toxicological and regulatory aspects.
Features:
Focused, comprehensive volume providing a different angle on theranostics in cancer intervention
Targets not only the multifunctionality of nanosystems but provides a comprehensive overview of niche technical aspects
Given the chemistries presented here, it provides both early-career and experienced readers with strategies from leading authorities in the field globally
Contents
Nanoparticles and Tumor microenvironment: challenges and opportunities
Materials and chemistries of tumor microenvironment-responsive delivery platforms
pH-responsive delivery nanoplatform in cancer theranostics
Enzyme-responsive delivery nanoplatform in cancer theranostics
Redox-responsive delivery nanoplatform in cancer theranostics
ROS-responsive delivery nanoplatform in cancer theranostics
Hypoxia-responsive delivery nanoplatform in cancer theranostics
Dual/multi-responsive delivery nanoplatforms in cancer theranostics
Temperature-responsive delivery nanoplatform in cancer theranostics
Light-responsive delivery nanoplatform in cancer theranostics
Magnetic field-responsive delivery nanoplatform in cancer theranostics
Ultrasound-responsive delivery nanoplatform in cancer theranostics
Exogenous dual/multi-responsive delivery platforms in cancer theranostics
Aptamer-based targeting of nanoplatforms for cancer theranostics
Peptide-based targeting of nanoplatforms for cancer theranostics
Antibody-based targeting of nanoplatforms for cancer theranostics
Carbohydrate-based targeting of nanoplatforms for cancer theranostics
Subcellular targeting of nanoparticles for cancer theranostics
Characterization techniques for stimuli-responsive delivery nanoplatforms in cancer treatment
Toxicological aspects of tumor microenvironment-responsive nanoplatforms
Commercialization challenges of tumor microenvironment-responsive nanoplatforms
